VIETNAM PHARMACEUTICAL INDUSTRY

The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018. By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 – 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,

Abbreviations

Report summary

  1. Business environment

1.1. Macroeconomic situation

1.2. Legal framework

1.3. Trade Agreements

  1. Pharmaceutical Industry Overview

2.1. Global Pharmaceutical Industry

2.1.1. Production – Consumption

2.1.2. Export – Import

2.1.3. Production and Consumption Situation in major countries

2.1.4. Large Enterprises in the world

2.2. Vietnam Pharmaceutical Industry Overview

2.2.1. History of Vietnam Pharmaceutical Industry

2.2.2. Industry Position

2.2.3. Industry Scale and Feature

2.2.4. Value Chain of Vietnam Pharmaceutical Industry

2.2.5. Raw materials

2.2.6. Production technology

2.2.7. R&D

2.2.8. Production

2.2.9. Consumption

2.2.10. Export – Import

2.2.11. Price movements

2.2.12. Distribution system

2.3. Risks and challenges

2.4. Industry planning

2.5. Driving forces and forecast

  1. Enterprise analysis

3.1. Profitability Ratios

3.2. Cost structure

3.3. Asset Management Ratios

3.4. Capital Structure

3.5. Solvency

3.6. Return on Investment

  1. Appendix of financial statements

 

DHG Pharmaceutical Joint Stock Company

TRAPHACO Joint Stock Company

Domesco Medical Import Export JSC

Imexpharm Pharmaceutical JSC

OPC Pharmaceutical JSC

S.P.M JSC

Vimedimex Medi – Pharma JSC

Ha Tay Pharmaceutical JSC

Ben Tre Pharmaceutical JSC

Lam Dong Pharmaceutical JSC

 

List of figures

Figure 1: Share of healthy sector and social assistance activities in total GDP, 2010-2019

Figure 2: Consumer price index of drug and medical service, 2012 – 2019

Figure 3: Population and population growth, 2010 – 2019

Figure 4: VND/USD exchange rate, 1/2013 – 12/2019

Figure 5: VND/CNY exchange rate, 1/2016 – 12/2019

Figure 6: Import of pharmaceutical products, 2012-2019e

Figure 7: Quantity of new drugs licensed by FDA, 2010 – 2019

Figure 8: World E&D investment costs, 2010-2024f

Figure 9: Top 10 enterprises with the largest R&D costs, 2018

Figure 10: Top 10 enterprises with the largest R&D costs, 2024

Figure 11: Revenue of the global pharmaceutical industry, 2010 – 2019e

Figure 12: Degree of risk from loss of patent protection, 2012-2019e 

Figure 14: World sales of prescription and generic drug, 2010-2019e

Figure 13: Share of pharmaceutical sales by technology, 2010-2019e

Figure 15: Pharmaceutical consumption market share by group, 2018

Figure 16: Spending on medicines by treatment area, 2018

Figure 17: Net revenue of manufactures per capita, 2014-2019e

Figure 18: Growth of Chinese pharmaceutical revenue, 2012-2018

Figure 19: Top 10 world pharmaceutical enterprises by revenue and R&D costs, 2019

Figure 20: Import of raw materials, 2013 – 2019e

Figure 22: Import of pharmaceutical raw materials, 2018 – 2019e

Figure 23: Average capital, fixed assets and long-term average investment of enterprises, 2010 – 2018

Figure 24: Number of enterprises and workers in medicine, chemical and pharmaceutical manufacturing sectors, 2010 – 2018

Figure 25: Net Revenue and profit before tax, 2010 – 2018

Figure 26: Domestic pharmaceutical production value, 2010 – 2019e

Figure 27: The market value of pharmaceutical industry, 2013 – 2019e

Figure 28: Value ratio of domestically produced medicines in Vietnam, 2010 – 2019e

Figure 29: Domestically produced medicine consumption, 2010 – 2019e

Figure 30: Spending on medicines in Vietnam, 2009 – 2019e

Figure 31: Spending on medicines per capita in some countries, 2018e

Figure 32: Structure of drug consumption by channel, 2013- 2019e

Figure 33: Situation of patented and generic drugs, 2013-2019e

Figure 34: Market value of prescription drugs (ETC), 2011 – 2019e

Figure 35: Over-the-counter (OTC) market, 2013 – 2019e

Figure 36: OTC market share by sales channel, 2019e

Figure 37: Patented drugs (Patent), 2010 – 2019e

Figure 38: Generic drug market, 2013 – 2019e

Figure 39: Import of pharmaceutical products from a number of countries, 2018 – 2019e

Figure 41: Import of pharmaceutical products from India, 2013 – 2019e

Figure 42: Pharmaceutical exports, 2012-2019e

Figure 43: Top major exporting countries, 2019 

Figure 44: Drug declared and re-declared prices (increased), 2013-2018

Figure 46: Top distribution companies by revenue, 2018e

Figure 47: Sales of typical distribution chains, 2017-2018

Figure 48: The rate of unsatisfactory sample, 2010-2018

Figure 49: M&A of pharmaceutical industry, 2010-2019

Figure 50: Sales of prescription drug, 2017-2024f

Figure 51: Prescription drug sales of the top 10 largest companies, 2024f

Figure 52: Drug manufacturing by technology,2017-2024f

Figure 53: Growth of total drug consumption value in Vietnam, 2013-2013f

Figure 54: Median drug spending per capita, 2017-2023f

Figure 55: DHG shareholder structure, 2018

Figure 56: TRA shareholder structure, 2018

Figure 57: DMC shareholder structure, 2018

Figure 58: Imexpharm shareholder structure, 2018

Figure 59: OPC shareholder structure, 2018

Figure 60: SPM shareholder structure, 2018

Figure 61: Vimedimex shareholder structure, 2018

Figure 62: DHT shareholder structure, 2018

Figure 63: DBT shareholder structure, 2018

Figure 64: LDP shareholder structure, 2018

Figure 65: Gross profit margin, 2017 – 2018

Figure 66: Selling expenses, 2017-2018

Figure 67: General and administration expenses, 2017-2018

Figure 68: Number of inventory days, 2018

Figure 72: Average payment period, 2018

Figure 73: Payment index, 2017-2018

Figure 74: Profit ratio, 2017 – 2018

 

List of tables

Table 1: Drug exporting countries, 2016-2018

Table 2: Countries importing drugs, 2016-2018

Table 3: General information about the US health sector, 2018e

Table 4: General information about the Japanese health sector, 2018e

Table 5: General information about the German health sector, 2018e

Table 6: Some main machines and equipment in the Pharmaceutical production line

Table 7 Origin of machinery and equipment of some big pharmaceutical

production companies

 

Table 8: Average R&D cost for new drug production

Table 9 Statistics of drug production by categories, 2013 – 2019e

Table 10: M&A of pharmaceutical manufacturing group, 2016 – 2019

Table 11:Top import partners of Vietnam, 2019

Table 12: Top pharmaceutical importing enterprises, 2019

Table 13: Top exporters, 2019

Table 14: Statistics of differences in selling prices of some drugs at pharmacies, 2019

Table 15: Number of health facilities, 2012 – 2017

Table 16: Typical drugstore chains, 2019

Table 17: M&A of pharmaceutical distribution group, 2017 – 2018

Table 18: Top 15 M&A in the world, 2019

Table 19: Top technology enterprises in Biotechnology, 2024

Table 20: 10 typical pharmaceutical enterprises in 2018